Patents Assigned to Novozymes Biopharma DIC A/S
  • Albumin variants
    Patent number: 8822417
    Abstract: Variants of a parent albumin having altered plasma half-life compared with a parent albumin are described. Fusion polypeptides and conjugates including the variant albumin are also described. Embodiments include, but are not limited to, a polypeptide which is a variant of albumin, including one or more alterations at one or more positions corresponding to 104, 105, 106, 107, 108, 109, 110, 111, 112, 113, 114, 115, 116, 117, 118, 119 and 120 in SEQ ID NO: 2.
    Type: Grant
    Filed: May 4, 2012
    Date of Patent: September 2, 2014
    Assignee: Novozymes Biopharma DIC A/S
    Inventors: Jan Terje Andersen, Bjorn Dalhus, Inger Sandlie, Jason Cameron, Andrew Plumridge, Esben Peter Friis, Karen Delahay